Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02734680
What this trial is testing

IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Not applicableWithdrawnNCT03707444
What this trial is testing

A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer

Who this might be right for
Cancer PancreasPain SyndromeCancer Related Pain
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT02332863
What this trial is testing

Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
University of Colorado, Denver 44
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Testing effectiveness (Phase 2)Study completedNCT00550836
What this trial is testing

Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 104
Testing effectiveness (Phase 2)Study completedNCT00397787
What this trial is testing

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
National Cancer Institute (NCI) 64
Early research (Phase 1)Study completedNCT00480584
What this trial is testing

A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT01560949
What this trial is testing

Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)WithdrawnNCT00386399
What this trial is testing

Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT04172532
What this trial is testing

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8
National Cancer Institute (NCI) 92
Not applicableLooking for participantsNCT07429487
What this trial is testing

Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

Who this might be right for
Breast CancerColorectal CancerOvarian Adenocarcinoma+2 more
Centre Antoine Lacassagne 98
Not applicableLooking for participantsNCT05376592
What this trial is testing

Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma

Who this might be right for
Pancreas AdenocarcinomaCachexia
Wake Forest University Health Sciences 100
Not applicableLooking for participantsNCT05851534
What this trial is testing

Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas

Who this might be right for
PrehabilitationPancreas CancerSurgery+1 more
Maastricht University Medical Center 2,575
Testing effectiveness (Phase 2)UnknownNCT06202014
What this trial is testing

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

Who this might be right for
Pancreatic CancerRadiotherapyEnvafolimab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 43
Testing effectiveness (Phase 2)Ended earlyNCT04176952
What this trial is testing

PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Neoplasms Pancreatic
Judith Dixon-Hughes 31
Early research (Phase 1)Study completedNCT02894944
What this trial is testing

Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Seoul National University Hospital 9
Testing effectiveness (Phase 2)Ended earlyNCT01562899
What this trial is testing

MEK162 and AMG 479 in Patients With Selected Solid Tumors

Who this might be right for
Metastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma
Pfizer 77
Testing effectiveness (Phase 2)Ended earlyNCT00336700
What this trial is testing

A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Herbert J. Zeh, III MD, FACS 25
Large-scale testing (Phase 3)Looking for participantsNCT04969731
What this trial is testing

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
GC Cell Corporation 408
Not applicableStudy completedNCT03808272
What this trial is testing

AXIOS CHINA (E7148)

Who this might be right for
Pancreatic Pseudocyst and Walled-off Necrosis
Boston Scientific Corporation 31
Next Page